Article info

Download PDFPDF
CP-017 Incidence of neutropenia due to the use of peginterferon alpha 2a/2b during the treatment for chronic hepatitis C infection (VHC)

Authors

Citation

Blanquer E, Candela M, Palacios E, et al
CP-017 Incidence of neutropenia due to the use of peginterferon alpha 2a/2b during the treatment for chronic hepatitis C infection (VHC)

Publication history

  • First published February 24, 2014.
Online issue publication 
February 24, 2014

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.